Periostin family of proteins: Therapeutic targets for heart disease
被引:70
作者:
Litvin, J
论文数: 0引用数: 0
h-index: 0
机构:Temple Med Sch, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA
Litvin, J
Zhu, SM
论文数: 0引用数: 0
h-index: 0
机构:Temple Med Sch, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA
Zhu, SM
Norris, R
论文数: 0引用数: 0
h-index: 0
机构:Temple Med Sch, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA
Norris, R
Markwald, R
论文数: 0引用数: 0
h-index: 0
机构:Temple Med Sch, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA
Markwald, R
机构:
[1] Temple Med Sch, Dept Anat & Cell Biol, Philadelphia, PA 19140 USA
[2] Temple Med Sch, Cardiovasc Res Grp, Philadelphia, PA 19140 USA
[3] Med Univ S Carolina, Dept Anat & Cell Biol, Charleston, SC 29425 USA
来源:
ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY
|
2005年
/
287A卷
/
02期
关键词:
periostin;
heart disease;
D O I:
10.1002/ar.a.20237
中图分类号:
R602 [外科病理学、解剖学];
R32 [人体形态学];
学科分类号:
100101 ;
摘要:
The common features between periostin and PLF are their shared homologies and their expression as isoforms generated from a single gene. The biological significance of alternative splicing in the heart has recently become apparent in the studies by Xu et al. (2005) and Cooper (2005). The difference between the isoforms of periostin lies in their temporal and spatial pattern of expression, reflecting possibly different functions for each. Upregulation during development and/or in response to damage and their role in cell adhesion possibly through integrins suggests a function in tissue remodeling (Markwald et al., 2005). Modulating their expression and/or interaction with the integrins may lead to therapeutic alternatives during cardiovascular disease and/or oncogenesis.